Home NEWS AND MEDIA

NEWS AND MEDIA

Mar 2025

NeuExcell Therapeutics Initiates First-in-Human Clinical Trial of NXL-001 to Treat Alzheimer's Disease

Learn more
May 2024

NeuExcell will present its stroke NHP data at the ASGCT Annual Meeting on May 10, 2024 10,

Learn more
Mar 2024

NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy

Learn more
Dec 2023

NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA

Learn more
May 2023

NeuExcell Therapeutics Raises $15+ Million Pre-A+ Round

Philadelphia, PA., May 4, 2023– NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $15+ million Series Pre-A+ financing round.

Learn more